Moderna’s Covid-19 Coronavirus vaccine would be 94.5% effective. Its CEO talks about the price it would have.
We have reached this point in the race to develop a vaccine against Coronavirus Covid-19 where the multiple projects running in parallel begin to demonstrate the results obtained in their effectiveness tests.
Among all the experimental vaccines in process, Moderna’s gave us a relative surprise at show which also achieved an efficiency rate of 94.5%. Very close to Pfizer and other more popular ones.
Now, backed by those figures, Moderna and her executive team have begun to talk about the cost that each dose would then have.
A near average price, covered by government, in theory
According to a report from the news agency ., Moderna’s CEO, Stephane Bancel, has given an interview to the German weekly Welt am Sonntag.
There, the manager revealed the cost range that they have projected for each dose of their experimental vaccine. Which would be sold to governments for an individual price of between USD $ 25 and USD $ 37. Depending on the quantity that is ordered by each country:
So our vaccine costs roughly the same as a flu shot, which is between $ 10 and $ 50.
Nothing has been signed yet, but we are close to reaching an agreement with the Commission of the European Union. We want to comply with Europe and we are in constructive talks.
They are the words of Bancel, where he seeks to justify the cost. It sounds relatively high, especially if we consider that AstraZeneca he was perhaps proposing to sell the vaccine at 10% of the price estimated by Moderna.
In the most recent rumors related to this negotiation, it is stated that the European Commission is trying to reach an agreement with Moderna to supply millions of doses but for a price below USD $ 25 per dose.